In this article we will dive into IRADIMED CORP (NASDAQ:IRMD) as a possible candidate for quality investing. Investors should always do their own research, but we noticed IRADIMED CORP showing up in our Caviar Cruise quality screen, which makes it worth to investigate a bit more.
What matters for quality investors.
Over the past 5 years, IRADIMED CORP has experienced impressive revenue growth, with 18.22% increase. This demonstrates the company's ability to effectively expand its top line and suggests a positive outlook for future revenue generation.
The ROIC excluding cash and goodwill of IRADIMED CORP stands at 58.86%, reflecting the company's strong financial management and profitability. This metric underscores its ability to generate favorable returns on the capital invested in its core operations.
With a favorable Debt/Free Cash Flow Ratio of 0.0, IRADIMED CORP showcases its sound financial discipline and cash flow management. This ratio indicates the company's ability to service its debt obligations while maintaining sufficient free cash flow for future investments or operational needs.
The Profit Quality (5-year) of IRADIMED CORP stands at 154.0%, highlighting its ability to consistently generate reliable profits. This metric underscores the company's strong business fundamentals and reinforces its position as a financially stable entity.
IRADIMED CORP has consistently achieved strong EBIT growth over the past 5 years, with a 64.69% increase. This underscores the company's effective management of its operating income and suggests a positive outlook for future profitability.
IRADIMED CORP has achieved superior EBIT 5-year growth compared to its Revenue 5-year growth. This demonstrates the company's ability to maximize its profitability through effective cost management and operational strategies.
What is the full fundamental picture of NASDAQ:IRMD telling us.
ChartMill assigns a proprietary Fundamental Rating to each stock. The score is computed daily by evaluating various fundamental indicators and properties. The score ranges from 0 to 10.
Overall IRMD gets a fundamental rating of 7 out of 10. We evaluated IRMD against 205 industry peers in the Health Care Equipment & Supplies industry. IRMD scores excellent points on both the profitability and health parts. This is a solid base for a good stock. IRMD is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings would make IRMD suitable for growth and quality investing!
More ideas for quality investing can be found on ChartMill in our Caviar Cruise screen.
Keep in mind
Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.